全文获取类型
收费全文 | 88022篇 |
免费 | 44953篇 |
国内免费 | 290篇 |
专业分类
耳鼻咽喉 | 1800篇 |
儿科学 | 4322篇 |
妇产科学 | 771篇 |
基础医学 | 17801篇 |
口腔科学 | 5206篇 |
临床医学 | 13374篇 |
内科学 | 25405篇 |
皮肤病学 | 8045篇 |
神经病学 | 14359篇 |
特种医学 | 3453篇 |
外科学 | 15739篇 |
综合类 | 76篇 |
一般理论 | 27篇 |
预防医学 | 4551篇 |
眼科学 | 1614篇 |
药学 | 7126篇 |
中国医学 | 1240篇 |
肿瘤学 | 8356篇 |
出版年
2023年 | 109篇 |
2022年 | 81篇 |
2021年 | 1796篇 |
2020年 | 5333篇 |
2019年 | 11160篇 |
2018年 | 10488篇 |
2017年 | 11727篇 |
2016年 | 12641篇 |
2015年 | 12757篇 |
2014年 | 12802篇 |
2013年 | 13365篇 |
2012年 | 5899篇 |
2011年 | 5679篇 |
2010年 | 9882篇 |
2009年 | 6048篇 |
2008年 | 3020篇 |
2007年 | 1876篇 |
2006年 | 1784篇 |
2005年 | 1484篇 |
2004年 | 1160篇 |
2003年 | 1094篇 |
2002年 | 1003篇 |
2001年 | 694篇 |
2000年 | 478篇 |
1999年 | 161篇 |
1998年 | 93篇 |
1997年 | 65篇 |
1996年 | 57篇 |
1995年 | 58篇 |
1994年 | 36篇 |
1993年 | 36篇 |
1992年 | 55篇 |
1991年 | 40篇 |
1990年 | 29篇 |
1989年 | 26篇 |
1988年 | 19篇 |
1987年 | 22篇 |
1986年 | 19篇 |
1985年 | 17篇 |
1984年 | 23篇 |
1983年 | 10篇 |
1982年 | 11篇 |
1981年 | 13篇 |
1980年 | 11篇 |
1979年 | 9篇 |
1978年 | 18篇 |
1973年 | 10篇 |
1971年 | 9篇 |
1968年 | 9篇 |
1967年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Hyun Cheol Chung MD PhD Yoon-Koo Kang MD PhD Zhendong Chen MD Yuxian Bai MD Wan Zamaniah Wan Ishak MD Byoung Yong Shim MD Young Lee Park MD Dong-Hoe Koo MD PhD Jianwei Lu MD Jianming Xu MD Hong Jae Chon MD Li-Yuan Bai MD Shan Zeng MD Ying Yuan MD Yen-Yang Chen MD Kangsheng Gu MD Wen Yan Zhong PhD Shu Kuang MD Chie-Schin Shih MD Shu-Kui Qin MD PhD 《Cancer》2022,128(5):995-1003
2.
Kim Jung Wan Eom Youngsub Park Wonkyung Song Jong Suk Jeong Ji Won Park Seh Kwang Kim Hyo Myung 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(10):3275-3283
Graefe's Archive for Clinical and Experimental Ophthalmology - To compare visual outcomes between two types of mix-and-match implanted trifocal extended-depth-of-focus (EDoF) and trifocal... 相似文献
3.
Kim Sung Jin Park Min Uk Chae Han Kyu Nam Wook Kim So Won Yu Hoon Kim Han Gwun Kang Gil Hyun Park Jong Yeon 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(2):403-410
International Journal of Clinical Oncology - Previous studies have shown a relationship between the occurrence and recurrence of prostate cancer; however, this relationship remains controversial.... 相似文献
4.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
5.
Darren Ming‐Chun Poon 《Asia-Pacific Journal of Clinical Oncology》2020,16(Z3):18-23
For advanced and metastatic urothelial carcinomas (UCs), platinum (preferably cisplatin)‐based chemotherapy has been the standard treatment for many years. However, many patients are ineligible for cisplatin‐based chemotherapy because of poor performance status and/or other age‐related conditions. At the other end of the spectrum, patients with localized non‐muscle–invasive bladder cancer who are unresponsive to intravesical Bacillus Calmette‐Guérin (BCG) treatment often face radical cystectomy as the only option. In recent years, the application of immunotherapy in the form of immune‐checkpoint inhibitors has provided viable alternatives in the second‐line postplatinum and first‐line cisplatin‐ineligible settings. Recent and ongoing clinical trials are also assessing the safety and efficacy of immunotherapy for neoadjuvant and adjuvant uses before/after cystectomy, for BCG‐unresponsive cases, and for combination treatments that include the newer indoleamine 2,3‐dioxygenase‐1 inhibitors and/or BCG. This review summarizes recent developments in immunotherapy for UCs. 相似文献
6.
7.
8.
9.
Javad Sharifi‐Rad Shahira M. Ezzat Mahitab H. El Bishbishy Dima Mnayer Farukh Sharopov Ceyda S. Kl Monica Neagu Carolina Constantin Mehdi Sharifi‐Rad Maria Atanassova Silvana Nicola Giuseppe Pignata Bahare Salehi Patrick V. T. Fokou Natlia Martins 《Phytotherapy research : PTR》2020,34(7):1474-1518
Rosmarinus species are aromatic plants that mainly grow in the Mediterranean region. They are widely used in folk medicine, food, and flavor industries and represent a valuable source of biologically active compounds (e.g., terpenoids, flavonoids, and phenolic acids). The extraction of rosemary essential oil is being done using three main methods: carbon dioxide supercritical extraction, steam distillation, and hydrodistillation. Furthermore, interesting antioxidant, antibacterial, antifungal, antileishmanial, anthelmintic, anticancer, anti‐inflammatory, antidepressant, and antiamnesic effects have also been broadly recognized for rosemary plant extracts. Thus the present review summarized data on economically important Rosmarinus officinalis species, including isolation, extraction techniques, chemical composition, pharmaceutical, and food applications. 相似文献